Category Archives

2 Articles

Posted by admin on

Rutgers Cancer Institute in New Jersey Receives A $1.5 Million Pledge from Omar Boraie

Urban developer and philanthropist, Omar Boraie pledges $1.50 million to the Rutgers Cancer Institute, a research & development institution, in N.J. The pledge was made to meet the ’18 Chair Challenge Campaign initiated by a donor who encourages other donors to match $1.5 million. Mr. Boraie made his contribution in 2015 and holds the Endowment Chair to support the institution and further advance precision medicine. He is hoping that others are inspired to support the institute and join the campaign as he was to help cancer patients. The challenge is for a good cause and expected to provide millions of patients alternatives for genomic science treatments and diagnosis.

Omar Boraie has years of involvement in cancer research and experience in chemistry, based on a report issued by Newswise News, in October 2015.The Chair at Rutgers Cancer Institute represents the standard of higher education and the commitment of the institution and university. New Jersey State University is part of the institute and the state’s only national institution inclusive cancer center. Boraie Development LLC, a property management company and developer of residential and commercial real estate helped to develop the healthcare community in New Brunswick.

Rutgers Cancer Institute will use all proceeds donated to the ’18 Chair Challenge to support the advancement of precision medicine. The medical treatment involves analytical study of the patient’s genetics and treating tumors based on result from genetic testing. It provides oncologists with the ability to prescribe therapies for cancer patients that meets individual needs. The much-needed alternative treatment is good news to patients who are experiencing non-responsive cancers and need a different medicine approach. Omar Boraie is hoping the Boraie Family’s pledge exceeds the expectation of the ’18 Chair Challenge Campaign and fulfil the mission of the institution.

The vision Omar Boraie had for New Brunswick for more than 35 years (http://www.njbiz.com/article/20141230/NJBIZ01/141239989/the-visionary-omar-boraie-has-seen-the-potential-of-new-brunswick-for-four-decades) after moving from Egypt to the United States is now reality. He has overseen the family owned company for decades and serves as the President of Boraie Development. With his sons, Waseem and Sam Boraie serving as Co-presidents, the real estate development and management firm successfully completed The Aspire project. According to Bloomberg.com, the luxury building is adjacent to the Children’s Cancer Institute and was built to attract nurses, doctors, specialists, professors, and teachers. Mr. Boraie ties to the New Brunswick Downtown community extends to support for research & development and providing luxury accommodations to professionals.

 

Posted by admin on

Mikhail Blagosklonny: Cancer and Aging Scientist and Researcher

Mikhail Blagosklonny is a scientist who currently researches aging and cancer. He earned both his M.D. and his PhD. in cardiology and experimental medicine from the First Pavlov State Medical University of St. Petersburg, Russia. In 2002, he was appointed associate professor of medicine at at New York Medical College, Valhalla, NY. He was later appointed senior scientist at Ordway Research Institute in Albany, New York until 2009. He is now one of the leading professors in the study of oncology at the Roswell Park Cancer Institute in Buffalo, New York. This institute was the first medical facility for the treatment of cancer and its research in the United States.

Mikhail Blagosklonny’s research includes cancer therapy and targeted cancer therapies protecting the cells in the human body from damage. He also studies the biological causes of aging and the effects of anti-aging drugs on this process. Based on his extensive research in the area of anti-cancer therapy, he suggested and recommended using a popular cancer drug known as rapamycin, as a an effective treatment to stop the proliferation of tumor cells and extending the life of humans. The Helmholtz Association of German Research Centres on Research Gate recently published a study of rapamycin and its known affects on the increase of the lifespan in mice. This effect may be the result of the suppression of tumors and their growth. Tumors represent the main causes of death in mice.

Rapamycin is a therapeutic drug on tandfonline.com with immunosuppressant and anti-tumor properties. Rapamycin affects tumor cells through the regulation of mTOR protein kinase. mTOR controls cell growth, reproductions of the cell, movement of the cell, protein synthesis, transcription, and the survival of the cell. Rapamycin inhibits or blocks this protein kinase from allowing the cancer cells to proliferate, inducing tumor cell apoptosis or cell death and suppressing angiogenesis or the creation of veins within tumors.